davamotecan pegadexamer (EP0057) / Lumos Pharma, Ellipses Pharma 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
davamotecan pegadexamer (EP0057) / Ellipses Pharma
NCT04669002 / 2020-003083-98: EP0057 in Combination With Olaparib in Advanced Ovarian Cancer

Completed
2
34
Europe, US
EP0057, Olaparib tablets, Lynparza
Ellipses Pharma
Ovarian Cancer
02/23
05/23
NCT05411679: EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer

Withdrawn
2
115
RoW
EP0057, Olaparib tablets
Ellipses Pharma
Gastric Cancer, Small-cell Lung Cancer
08/24
12/24

Download Options